GSK Reports Lower H1 Attributable Profit; Turnover Rises

07:26 AM EDT, 07/28/2026 (MT Newswires) -- GSK (GSK.L) said Tuesday that attributable profit declined in the first half, while turnover increased year over year. Profit attributable to shareholders for the six months ended June 30 was 2.17 billion pounds sterling, compared with 3.07 billion pounds a year earlier. EPS moved to 0.534 pound from 0.744 pound. The British drugmaker's turnover was 16.04 billion pounds, compared with 15.5 billion pounds a year ago. Meanwhile, the board declared a second interim dividend of 0.17 pound per share for the period, payable Oct. 8 to shareholders on record Aug. 14. It paid 0.16 pound per share a year ago. The company confirmed its guidance for full-year 2026, including turnover growth of between 3% and 5% as well as core EPS growth of 7% to 9%.